Fingerprint
Dive into the research topics of 'Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically